“Fibronectin as a Nexus of Inflammation and Dysmetabolism in Type 2 Diabetes”, AIMCJ, vol. 2, no. 2, pp. 49–59, Aug. 2025, doi: 10.58564/AIMCJ2.2.2025.128.